A rapid liquid chromatography-tandem mass spectrometry analysis of whole blood sirolimus using turbulent flow technology for online extraction

Clinical Chemistry and Laboratory Medicine

Volumn 46, Issue 11, 2008, Pages 1631-1634

  Wang, Sihe ^a   Miller, Abby ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Liquid chromatography; Mass spectrometry; Sirolimus; Turbulent flow

Indexed keywords

32 DESMETHOXYRAPAMYCIN; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; RAPAMYCIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG BLOOD LEVEL; DRUG MONITORING; EXTRACTION; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIQUID CHROMATOGRAPHY; MEDICAL TECHNOLOGY; ONLINE SYSTEM; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; TURBULENT FLOW;

CALIBRATION; CHROMATOGRAPHY, LIQUID; HUMANS; POLYENES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SIROLIMUS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 56549089409     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2008.303     Document Type: Article

References (11)

1. Stenton SB, Partovi N, Ensom MH. Sirolimus - the evidence for clinical pharmacokinetic monitoring. Clin Pharmacokinet 2005;44:769-86.
2. Mahalati K, Kahan BD. Clinical pharmacokinetics of sirolimus. Clin Pharmacokinet 2001;40:573-85.
3. Yang Z, Peng Y, Wang S. Immunosuppressants: pharmacokinetics, methods of monitoring and role of high performance liquid chromatography/mass spectrometry. Clin Appl Immunol Rev 2005;5:405-30.
4. Morris RG, Salm P, Taylor PJ, Wicks FA, Theodossi A. Comparison of the reintroduced MEIA (R) assay with HPLC-MS/MS for the determination of whole-blood sirolimus from transplant recipients. Ther Drug Monit 2006;28:164-8.
5. Vicente FB, Smith FA, Peng Y, Wang SH. Evaluation of an immunoassay of whole blood sirolimus in pediatric transplant patients in comparison with high-performance liquid chromatography/tandem mass spectrometry. Clin Chem Lab Med 2006;44:497-9.
6. Wilson D, Johnston F, Holt D, Moreton M, Engelmayer J, Gaulier JM, et al. Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus. Clin Biochem 2006;39:378-86.
7. Grant RP, Cameron C, Mackenzie-McMurter S. Generic serial and parallel on-line direct-injection using turbulent flow liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2002;16:1785-92.
8. Zimmer D, Pickard V, Czembor W, Muller C. Comparison of turbulent-flow chromatography with automated solid-phase extraction in 96-well plates and liquid-liquid extraction used as plasma sample preparation techniques for liquid chromatography-tandem mass spectrometry. J Chromatogr A 1999;854:23-35.
9. Ceglarek U, Lembcke J, Fiedler GM, Werner M, Witzigmann H, Hauss JP, et al. Rapid simultaneous quantification of immunosuppressants in transplant patients by turbulent flow chromatography combined with tandem mass spectrometry. Clin Chim Acta 2004;346:181-90.
10. Wilson DH, Sepe D, Barnes G. Inter-laboratory differences in sirolimus results from six sirolimus testing centers using HPLC tandem mass spectrometry (LC/MS/MS). Clin Chim Acta 2005;355:211-3.
11. Taylor PJ, Johnson AG. Quantitative analysis of sirolimus (Rapamycin) in blood by high-performance liquid chromatography electrospray tandem mass spectrometry. J Chromatogr B Biomed Appl 1998;718:251-7.